• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶10(HDAC10)的表达与DNA错配修复基因相关,是结肠癌预后良好的一个预测指标。

HDAC10 expression is associated with DNA mismatch repair gene and is a predictor of good prognosis in colon carcinoma.

作者信息

Tao Xiangxiang, Yan Yifeng, Lu Linming, Chen Bing

机构信息

Department of Pathology, Wannan Medical College, Wuhu, Anhui 241001, P.R. China.

Department of Forensic Pathology, Wannan Medical College, Wuhu, Anhui 241001, P.R. China.

出版信息

Oncol Lett. 2017 Oct;14(4):4923-4929. doi: 10.3892/ol.2017.6818. Epub 2017 Aug 24.

DOI:10.3892/ol.2017.6818
PMID:29085502
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5649613/
Abstract

Despite increasing evidence of the involvement of histone deacetylase (HDAC)10 in cancer tumorigenesis, the potential role of HDAC10 in colon cancer remains unclear. Oncomine database analysis revealed that HDAC10 mRNA was significantly upregulated in colon cancer. In an independent cohort, consistent with mRNA expression levels, constitutively high HDAC10 expression was observed in the cytoplasm and nucleus compared with in adjacent normal tissues (cytoplasm, 93.12±12.98 vs. 31.65±26.50%; nucleus, 84.16±19.23 vs. 68.64±19.00%). Cytoplasmic HDAC expression correlated with gender (r=0.265; P<0.05), lymph node metastasis (N stage; r=0.256; P<0.05) and distant metastasis (M stage; r=0.331; P<0.05) in paracarcinoma tissues. Cytoplasmic HDAC10 expression in tumors was not associated with the four DNA mismatch repair genes examined, but was negatively correlated with mutL homolog 1 (MLH1) (r=-0.244; P<0.05), mutS homolog (MSH)2 (r=-0.410; P<0.01) and MSH6 (r=-0.240; P<0.05) in paracarcinoma tissues. Similarly, nuclear HDAC10 expression was negatively correlated with MLH1 expression (r=-0.288; P<0.05). The findings of the current study suggest that HDAC10 expression is associated with good prognosis in colon cancer tissues and poor prognosis in paracarcinoma tissues with a potential involvement in DNA mismatch repair.

摘要

尽管越来越多的证据表明组蛋白去乙酰化酶(HDAC)10参与癌症肿瘤发生,但HDAC10在结肠癌中的潜在作用仍不清楚。Oncomine数据库分析显示,HDAC10 mRNA在结肠癌中显著上调。在一个独立队列中,与mRNA表达水平一致,与相邻正常组织相比,在细胞质和细胞核中观察到HDAC10持续高表达(细胞质,93.12±12.98%对31.65±26.50%;细胞核,84.16±19.23%对68.64±19.00%)。癌旁组织中细胞质HDAC表达与性别(r=0.265;P<0.05)、淋巴结转移(N分期;r=0.256;P<0.05)和远处转移(M分期;r=0.331;P<0.05)相关。肿瘤中细胞质HDAC10表达与所检测的四个DNA错配修复基因无关,但与癌旁组织中的错配修复蛋白1(MLH1)(r=-0.244;P<0.05)、错配修复蛋白2(MSH2)(r=-0.410;P<0.01)和MSH6(r=-0.240;P<0.05)呈负相关。同样,细胞核HDAC10表达与MLH1表达呈负相关(r=-0.288;P<0.05)。本研究结果表明,HDAC10表达与结肠癌组织的良好预后以及癌旁组织的不良预后相关,且可能参与DNA错配修复。

相似文献

1
HDAC10 expression is associated with DNA mismatch repair gene and is a predictor of good prognosis in colon carcinoma.组蛋白去乙酰化酶10(HDAC10)的表达与DNA错配修复基因相关,是结肠癌预后良好的一个预测指标。
Oncol Lett. 2017 Oct;14(4):4923-4929. doi: 10.3892/ol.2017.6818. Epub 2017 Aug 24.
2
Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.组蛋白去乙酰化酶10表达降低预示着胃癌患者预后不良。
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5872-9. eCollection 2014.
3
HDAC10 Is Positively Associated With PD-L1 Expression and Poor Prognosis in Patients With NSCLC.HDAC10与非小细胞肺癌患者的PD-L1表达及不良预后呈正相关。
Front Oncol. 2020 Apr 21;10:485. doi: 10.3389/fonc.2020.00485. eCollection 2020.
4
Histone deacetylase 10 suppresses proliferation and invasion by inhibiting the phosphorylation of β-catenin and serves as an independent prognostic factor for human clear cell renal cell carcinoma.组蛋白去乙酰化酶10通过抑制β-连环蛋白的磷酸化来抑制增殖和侵袭,并作为人类透明细胞肾细胞癌的独立预后因素。
Int J Clin Exp Med. 2015 Mar 15;8(3):3734-42. eCollection 2015.
5
Mismatch repair protein expression in patients with stage II and III sporadic colorectal cancer.II期和III期散发性结直肠癌患者错配修复蛋白的表达
Oncol Lett. 2018 May;15(5):8053-8061. doi: 10.3892/ol.2018.8337. Epub 2018 Mar 23.
6
[Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].658例结直肠癌错配修复蛋白表达与临床病理特征的相关性
Zhonghua Bing Li Xue Za Zhi. 2018 Nov 8;47(11):827-833. doi: 10.3760/cma.j.issn.0529-5807.2018.11.003.
7
HDAC10 as a potential therapeutic target in ovarian cancer.HDAC10作为卵巢癌潜在的治疗靶点。
Gynecol Oncol. 2017 Mar;144(3):613-620. doi: 10.1016/j.ygyno.2017.01.009. Epub 2017 Jan 7.
8
[Analysis of the relationship of DNA mismatch repair with clinicopathologic features and prognosis of colon cancer].[DNA错配修复与结肠癌临床病理特征及预后的关系分析]
Zhonghua Zhong Liu Za Zhi. 2015 Aug;37(8):591-6.
9
Improved survival with an intact DNA mismatch repair system in endometrial cancer.子宫内膜癌中具有完整DNA错配修复系统可改善生存率。
Obstet Gynecol. 2006 Nov;108(5):1208-15. doi: 10.1097/01.AOG.0000239097.42987.0c.
10
Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.采用四抗体免疫组织化学检测法对巴基斯坦人群结直肠癌错配修复缺陷进行筛查及其与组织病理学参数的相关性研究
World J Surg Oncol. 2017 Jun 26;15(1):116. doi: 10.1186/s12957-017-1158-8.

引用本文的文献

1
Histone Deacetylase Inhibitors Promote the Anticancer Activity of Cisplatin: Mechanisms and Potential.组蛋白去乙酰化酶抑制剂增强顺铂的抗癌活性:作用机制与潜力
Pharmaceuticals (Basel). 2025 Apr 11;18(4):563. doi: 10.3390/ph18040563.
2
A polyamine metabolism risk signature for predicting the prognosis and immune therapeutic response of kidney cancer.一种用于预测肾癌预后和免疫治疗反应的多胺代谢风险特征
Transl Cancer Res. 2023 Oct 31;12(10):2477-2492. doi: 10.21037/tcr-23-344. Epub 2023 Oct 24.
3
Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis.组蛋白去乙酰化酶在早期造血和红细胞生成的控制中发挥作用。
Int J Mol Sci. 2022 Aug 29;23(17):9790. doi: 10.3390/ijms23179790.
4
Histone deacetylase-10 liberates spermidine to support polyamine homeostasis and tumor cell growth.组蛋白去乙酰化酶-10 释放亚精胺以支持多胺稳态和肿瘤细胞生长。
J Biol Chem. 2022 Oct;298(10):102407. doi: 10.1016/j.jbc.2022.102407. Epub 2022 Aug 19.
5
Potential Involvement of , and in the Genetic Predisposition to Colorectal Cancer.、和在结直肠癌遗传易感性中的潜在作用。
Cancers (Basel). 2022 Jan 29;14(3):699. doi: 10.3390/cancers14030699.
6
Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma.基于组蛋白去乙酰化酶的透明细胞肾细胞癌新预后标志物的综合分析。
Cancer Med. 2021 Sep;10(18):6503-6514. doi: 10.1002/cam4.4156. Epub 2021 Jul 26.
7
Histone deacetylase 10, a potential epigenetic target for therapy.组蛋白去乙酰化酶 10,一种有治疗潜力的表观遗传学靶点。
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20210462.
8
Acetylation and Deacetylation of DNA Repair Proteins in Cancers.癌症中DNA修复蛋白的乙酰化与去乙酰化
Front Oncol. 2020 Oct 22;10:573502. doi: 10.3389/fonc.2020.573502. eCollection 2020.
9
Gestation and breastfeeding in schistosomotic mice differentially alters the expression of histone deacetylases (HDACs) in adult offspring.感染血吸虫的小鼠的妊娠和哺乳会在成年后代中差异地改变组蛋白去乙酰化酶 (HDACs) 的表达。
Mem Inst Oswaldo Cruz. 2020 Feb 3;114:e190366. doi: 10.1590/0074-02760190366. eCollection 2020.
10
Differences in the prognosis of gastric cancer patients of different sexes and races and the molecular mechanisms involved.不同性别和种族的胃癌患者预后差异及相关分子机制。
Int J Oncol. 2019 Nov;55(5):1049-1068. doi: 10.3892/ijo.2019.4885. Epub 2019 Sep 26.

本文引用的文献

1
HDAC10 as a potential therapeutic target in ovarian cancer.HDAC10作为卵巢癌潜在的治疗靶点。
Gynecol Oncol. 2017 Mar;144(3):613-620. doi: 10.1016/j.ygyno.2017.01.009. Epub 2017 Jan 7.
2
Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis.左半结肠癌与右半结肠癌的预后生存情况:一项系统评价与荟萃分析
JAMA Oncol. 2017 Feb 1;3(2):211-219. doi: 10.1001/jamaoncol.2016.4227.
3
HDAC10 promotes lung cancer proliferation via AKT phosphorylation.组蛋白去乙酰化酶10通过AKT磷酸化促进肺癌增殖。
Oncotarget. 2016 Sep 13;7(37):59388-59401. doi: 10.18632/oncotarget.10673.
4
Expression and Function of Histone Deacetylase 10 (HDAC10) in B Cell Malignancies.组蛋白去乙酰化酶10(HDAC10)在B细胞恶性肿瘤中的表达及功能
Methods Mol Biol. 2016;1436:129-45. doi: 10.1007/978-1-4939-3667-0_10.
5
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
6
Growth attenuation is associated with histone deacetylase 10-induced autophagy in the liver.生长减缓与肝脏中组蛋白去乙酰化酶10诱导的自噬相关。
J Nutr Biochem. 2016 Jan;27:171-80. doi: 10.1016/j.jnutbio.2015.08.031. Epub 2015 Sep 13.
7
Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7-HMGA2-Cyclin A2 Pathway.组蛋白去乙酰化酶10通过一条新的Let-7-HMGA2-细胞周期蛋白A2途径调控细胞周期G2/M期转换。
Mol Cell Biol. 2015 Oct;35(20):3547-65. doi: 10.1128/MCB.00400-15. Epub 2015 Aug 3.
8
Histone deacetylase 10 regulates DNA mismatch repair and may involve the deacetylation of MutS homolog 2.组蛋白去乙酰化酶10调节DNA错配修复,可能参与MutS同源物2的去乙酰化过程。
J Biol Chem. 2015 Sep 11;290(37):22795-804. doi: 10.1074/jbc.M114.612945. Epub 2015 Jul 28.
9
Histone deacetylase 10 suppresses proliferation and invasion by inhibiting the phosphorylation of β-catenin and serves as an independent prognostic factor for human clear cell renal cell carcinoma.组蛋白去乙酰化酶10通过抑制β-连环蛋白的磷酸化来抑制增殖和侵袭,并作为人类透明细胞肾细胞癌的独立预后因素。
Int J Clin Exp Med. 2015 Mar 15;8(3):3734-42. eCollection 2015.
10
Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.组蛋白去乙酰化酶10表达降低预示着胃癌患者预后不良。
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5872-9. eCollection 2014.